Insulin‐like growth factor I gene deletion causing intrauterine growth retardation and severe short stature

The first human case of a homozygous molecular defect in the gene encoding insulin‐like growth factor I (IGF‐I) is described. The patient was a 15‐year‐old boy from a consanguineous pedigree who presented with severe intrauterine growth failure, sensorineural deafness and mild mental retardation. Endocrine evaluation of the growth hormone (GH)–IGF‐I axis revealed elevated GH secretion, undetectable serum IGF‐I and normal serum IGF‐binding protein‐3, acid‐labile subunit, and GH‐binding activity. Analysis of the IGF‐I gene revealed a homozygous partial IGF‐I gene deletion involving exons 4 and 5, which encodes a severely truncated mature IGF‐I peptide. This patient demonstrates that complete disruption of the IGF‐I gene in man is compatible with life, and indicates a major role for IGF‐I in human fetal growth. In addition, his neurological abnormalities suggest that IGF‐I may be involved in central nervous system development. □ Insulin‐like growth factor I, growth disorders, intrauterine growth retardation, growth hormone resistance, sensorineural deafness

[1]  R. Baxter The somatomedins: insulin-like growth factors. , 1986, Advances in clinical chemistry.

[2]  R. Baxter,et al.  The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3. , 1993, The Journal of clinical endocrinology and metabolism.

[3]  D. Clemmons,et al.  Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I. , 1991, Endocrinology.

[4]  R. Baxter,et al.  Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. , 1990, The Journal of clinical endocrinology and metabolism.

[5]  T J Cole,et al.  Cross sectional stature and weight reference curves for the UK, 1990. , 1995, Archives of disease in childhood.

[6]  M. Ranke,et al.  A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. , 1988, Acta endocrinologica.

[7]  J. Baker,et al.  Effects of an Igf1 gene null mutation on mouse reproduction. , 1996, Molecular endocrinology.

[8]  F. Mcmorris,et al.  Insulin‐like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures , 1991, Journal of neuroscience research.

[9]  M. Preece,et al.  The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism. , 1992, The Journal of clinical endocrinology and metabolism.

[10]  A. Clark,et al.  The molecular pathology of pituitary hormone deficiency and resistance. , 1995, Bailliere's clinical endocrinology and metabolism.

[11]  G. Novelli,et al.  Laron dwarfism and mutations of the growth hormone-receptor gene. , 1989, The New England journal of medicine.

[12]  R. Naeye Do placental weights have clinical significance? , 1987, Human pathology.

[13]  J. Guevara-Aguirre,et al.  Growth hormone (GH) insensitivity due to primary GH receptor deficiency. , 1994, Endocrine reviews.

[14]  M. Binoux,et al.  Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. , 1986, Analytical biochemistry.

[15]  E. Rutanen,et al.  Insulin-like growth factors and their binding proteins. , 1990, Acta endocrinologica.

[16]  C. Bondy,et al.  Transient IGF-I gene expression during the maturation of functionally related central projection neurons , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  C. Bondy,et al.  Anatomy of the insulin-like growth factor system in the human testis. , 1993, Fertility and sterility.

[18]  W. Daughaday,et al.  A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. , 1957, The Journal of laboratory and clinical medicine.

[19]  N. Cameron,et al.  The Methods of Auxological Anthropometry , 1978 .

[20]  M. Savage,et al.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.

[21]  M. Preece,et al.  Clinical Features and Endocrine Status in Patients with Growth Hormone Insensitivity , 1993 .

[22]  A. Gunn,et al.  Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. , 1992, The Journal of pediatrics.

[23]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[24]  E. Froesch,et al.  Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Clemmons,et al.  Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. , 1992, The Journal of biological chemistry.

[26]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[27]  A. D'ercole Expression of Insulin‐like Growth Factor‐I in Transgenic Mice a , 1993, Annals of the New York Academy of Sciences.

[28]  M. Preece,et al.  Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). , 1993, The Journal of clinical endocrinology and metabolism.

[29]  V. Han,et al.  Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. , 1988, The Journal of clinical endocrinology and metabolism.

[30]  P. Caroni,et al.  Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors , 1990, The Journal of cell biology.

[31]  F. Hefti,et al.  Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons , 1995, Neuron.

[32]  D. K. Didier,et al.  Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. , 1986, The Journal of biological chemistry.

[33]  M. Preece,et al.  A monoclonal antibody to human insulin-like growth factor-I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor. , 1989, Journal of molecular endocrinology.

[34]  A. Ullrich,et al.  Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor , 1984, Nature.

[35]  M. Bothwell Insulin and somatemedin MSA promote nerve growth factor‐independent neurite formation by cultured chick dorsal root ganglionic sensory neurons , 1982, Journal of neuroscience research.

[36]  J. Milbrandt,et al.  Differential expression of insulin-like growth factor genes in rat central nervous system. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Chew,et al.  An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. , 1995, Endocrinology.

[38]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[39]  W. Daughaday,et al.  Somatomedin: Proposed Designation for Sulphation Factor , 1972, Nature.

[40]  P. Hindmarsh,et al.  GROWTH HORMONE SECRETION IN CHILDREN DETERMINED BY TIME SERIES ANALYSIS , 1988, Clinical endocrinology.

[41]  Y. Le Bouc,et al.  Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. , 1989, The Journal of clinical endocrinology and metabolism.